Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
about
Determinant Variables, Enteric Pathogen Burden, Gut Function, and Immune-Related Inflammatory Biomarkers Associated with Childhood Malnutrition: A Prospective Case-Control Study in Northeastern Brazil.Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in Tanzanian Infants.The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses.Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.Stimuli-responsive nanomaterials for therapeutic protein delivery.Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndromeIncreased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice.Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections.Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection.Increased Anti-Flagellin and Anti-Lipopolysaccharide Immunoglobulins in Pediatric Intestinal Failure: Associations With Fever and Central Line-Associated Bloodstream Infections.Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.Circulating Biomarkers of Gut Barrier Function: Correlates and Nonresponse to Calcium Supplementation among Colon Adenoma Patients.Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.Environmental Enteric Dysfunction in Children.Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver DysfunctionDietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome.Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.Latent cytomegalovirus infection exacerbates experimental colitis.Microbial translocation in HIV infection: causes, consequences and treatment opportunities.Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.Infant Nutritional Status and Markers of Environmental Enteric Dysfunction are Associated with Midchildhood Anthropometry and Blood Pressure in Tanzania.Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.Deficiency of stearoyl-CoA desaturase-1 aggravates colitogenic potential of adoptively transferred effector T cellsDissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy.Intestinal Microbiota Signatures Associated With Histological Liver Steatosis in Pediatric-Onset Intestinal Failure.Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.Markers of Environmental Enteric Dysfunction Are Associated With Neurodevelopmental Outcomes in Tanzanian Children.Phytosterols Synergize With Endotoxin to Augment Inflammation in Kupffer Cells but Alone Have Limited Direct Effect on Hepatocytes.Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction.Biomarkers of maternal environmental enteric dysfunction are associated with shorter gestation and reduced length in newborn infants in UgandaDysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer
P2860
Q30268540-2B82E4B6-4C4B-4BA7-A8B7-C7A0C9DD7BC0Q30276491-8FA6B462-0077-4374-8846-11BAD205F7E6Q33872782-6928B509-EFEB-4012-B897-54E485AA0458Q34023501-D403AE3D-B730-47D4-A61C-B02FFE716F2DQ34245386-1F6F492D-481C-4A77-B9F6-797A43C0F160Q35088244-02718CD2-85D1-4885-90B9-F9A716088154Q35570155-CC3FE8F6-AF65-422C-9C5D-320686FFDE5BQ35781494-A5C1B181-6746-44CC-8EBC-FB0D85489C90Q35927509-3C388339-B5A9-4A91-8BD5-3AB0CFC7BF2AQ35999844-97A72E56-2303-4893-8022-52F58A22541CQ36032021-BE2E352A-2275-4707-B1FA-3411805B6049Q36215719-CEC4724F-1B40-4020-8997-713590CBA431Q36333189-1D36FF84-2C06-48FB-ACD6-87B6DAD43BFDQ36619670-1F9AD3AF-1240-492B-AEF2-21FE4F6C7D82Q36937657-9D4BEDC2-2327-48FC-AB41-1D5DEB93616FQ37037319-A86B7CE2-6F1B-4A2D-8AE4-E7A37823B00CQ37094870-5E800909-4B35-45EA-89AC-5607BE3C2CB2Q37100225-62919423-E478-4738-BE43-39C57B4E8B91Q37119613-EA8D2BAE-E4EA-48C2-8C2E-E4CEEE2C9A12Q37413684-8E54B9CA-EA8C-48C6-ADF6-4E1D02FA2934Q38034068-C3B3CF7E-A873-43AD-97D7-7D954D60D78CQ38927355-7271C45F-7587-4A0A-9F34-4CAC13509452Q40203329-95577276-1BBA-4CEA-AF33-B4D547A92D08Q40813284-0C3C0961-E643-4667-8CA1-E0664A99193CQ41630494-19ADC304-47EB-4F7C-A2A4-AF3961E99539Q46209448-2266ED61-8F01-4FA8-A522-30EA9C508420Q46734774-4777D9E0-9B5B-4A32-B232-3F0064C47B72Q51082642-88213867-57F3-4B7B-BAEC-EEE08A57AD34Q52610317-5097B4F3-8829-4242-ACE8-69053FF4C893Q52759572-ED20FEAD-0A9F-43D4-9C5F-931DA94DA4DCQ54261441-B4691AEA-447F-43D8-85A3-75933ADCC9E3Q56909259-99359331-2BBF-430F-BA75-43BA5428E346Q58594003-A8E3CCE0-36F6-45D5-B042-9384B1A406E8
P2860
Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Detectable serum flagellin and ...... in human short bowel syndrome.
@ast
Detectable serum flagellin and ...... in human short bowel syndrome.
@en
Detectable serum flagellin and ...... in human short bowel syndrome.
@nl
type
label
Detectable serum flagellin and ...... in human short bowel syndrome.
@ast
Detectable serum flagellin and ...... in human short bowel syndrome.
@en
Detectable serum flagellin and ...... in human short bowel syndrome.
@nl
prefLabel
Detectable serum flagellin and ...... in human short bowel syndrome.
@ast
Detectable serum flagellin and ...... in human short bowel syndrome.
@en
Detectable serum flagellin and ...... in human short bowel syndrome.
@nl
P2093
P2860
P1476
Detectable serum flagellin and ...... in human short bowel syndrome.
@en
P2093
Andrew T Gewirtz
Concepción F Estívariz
Daniel A Moore
Dean P Jones
Jan-Michael Klapproth
John R Galloway
Junqiang Tian
Lorraine M Leader
Menghua Luo
P2860
P304
P356
10.1152/AJPREGU.00650.2007
P577
2007-11-14T00:00:00Z